Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07462312

Digital Biofeedback for Combat Veterans Diagnosed With PTSD

Evaluating the Efficacy of the "Mental Gym®" Biofeedback-Based Intervention for Combat Veterans Diagnosed With PTSD: A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
NeuroBrave ltd. · Industry
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled trial (RCT) will evaluate the effectiveness of a digital biofeedback-based intervention ("Mental Gym®") designed to reduce Posttraumatic Stress Disorder (PTSD) symptoms and improve mental health. The intervention combines daily HRV biofeedback exercises using a wearable device (Garmin watch), a dedicated mobile application, and weekly group guidance sessions. A delayed-intervention control group design will be used. To account for expected attrition and ensure a final sample of 60 participants, approximately 80 subjects will be recruited. Physiological and self-report data will be collected pre- and post-intervention, weekly during the intervention, and at follow-ups (3 months post-intervention). The study population consists of combat veterans diagnosed with PTSD.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMental Gym® Biofeedback SystemThe intervention is an 8-week hybrid program designed to reduce symptoms of PTSD and improve mental health. The program includes weekly online sessions (via Zoom) with a specialist psychologist experienced in biofeedback and trauma therapy. These sessions guide participants through the program, provide education on trauma and autonomic system and explain the biofeedback exercises. In addition to the weekly group sessions, participants engage in a dailyself-practice delivered through the NeuroBrave Sense mobile application, utilizing the provided wearable device ( Garmin watch) for real time biofeedback practices. Supplementary mental practice assignments are also delivered to participants via WhatsApp.

Timeline

Start date
2025-09-15
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2026-03-10
Last updated
2026-03-10

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT07462312. Inclusion in this directory is not an endorsement.